EP Patent

EP3831389A1 — Topical pharmaceutical formulations comprising crisaborole for treating inflammatory-related conditions

Assigned to Anacor Pharmaceuticals LLC · Expires 2021-06-09 · 5y expired

What this patent protects

Topical pharmaceutical formulations, and methods of treating inflammatory conditions with these formulations, are disclosed.

USPTO Abstract

Topical pharmaceutical formulations, and methods of treating inflammatory conditions with these formulations, are disclosed.

Drugs covered by this patent

Patent Metadata

Patent number
EP3831389A1
Jurisdiction
EP
Classification
—
Expires
2021-06-09
Drug substance claim
No
Drug product claim
No
Assignee
Anacor Pharmaceuticals LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.